WallStreetZenWallStreetZen

NASDAQ: PRVA
Privia Health Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRVA

Based on 9 analysts offering 12 month price targets for Privia Health Group Inc

Min Forecast
$23.00-5.62%
Avg Forecast
$30.44+24.92%
Max Forecast
$34.00+39.52%

Should I buy or sell PRVA stock?

Based on 9 analysts offering ratings for Privia Health Group Inc.

Strong Buy
Strong Buy
4 analysts 44.44%
Buy
4 analysts 44.44%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PRVA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PRVA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their PRVA stock forecasts and price targets.

PRVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-13
lockedlocked$00.00+00.00%2025-11-13
lockedlocked$00.00+00.00%2025-11-12
lockedlocked$00.00+00.00%2025-11-10
lockedlocked$00.00+00.00%2025-11-10
Evercore ISI Group
Top 42%
59
BuyMaintains$30.00+23.10%2025-11-07
Citizens
Bottom 1%
1
BuyMaintains$31.00+27.21%2025-11-07
Stephens & Co.
Bottom 5%
5
Strong BuyReiterates$32.00+31.31%2025-09-24
JMP Securities
Bottom 14%
14
BuyMaintains$30.00+23.10%2025-08-29

1 of 1

Forecast return on equity

Is PRVA forecast to generate an efficient return?

Company
N/A
Industry
20.99%
Market
230.27%

Forecast return on assets

Is PRVA forecast to generate an efficient return on assets?

Company
N/A
Industry
17.25%

PRVA earnings per share forecast

What is PRVA's earnings per share in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$0.17+12.93%
Avg 2 year Forecast
$0.33+117.73%
Avg 3 year Forecast
$0.45+198.2%
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PRVA revenue forecast

What is PRVA's revenue in the next 3 years based on estimates from 21 analysts?

Avg 1 year Forecast
$3.4B+67.39%
Avg 2 year Forecast
$3.5B+69.1%
Avg 3 year Forecast
$3.6B+76.25%
PRVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRVA earnings growth forecast

How is PRVA forecast to perform vs Health Information Services companies and vs the US market?

Company
45.01%
Industry
36.43%
Market
42.81%
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PRVA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PRVA revenue growth forecast

How is PRVA forecast to perform vs Health Information Services companies and vs the US market?

Company
20.45%
Industry
9.39%
Market
25.31%
PRVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRVA vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PRVA$24.37$30.44+24.92%Strong Buy
HTFL$32.25$39.50+22.48%Strong Buy
TXG$18.81$16.29-13.42%Buy
PGNY$26.37$27.14+2.93%Buy
HNGE$48.91$60.07+22.82%Strong Buy
View Top Health Information Service Stocks

Privia Health Group Stock Forecast FAQ

Is Privia Health Group Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: PRVA) stock is to Strong Buy PRVA stock.

Out of 9 analysts, 4 (44.44%) are recommending PRVA as a Strong Buy, 4 (44.44%) are recommending PRVA as a Buy, 1 (11.11%) are recommending PRVA as a Hold, 0 (0%) are recommending PRVA as a Sell, and 0 (0%) are recommending PRVA as a Strong Sell.

If you're new to stock investing, here's how to buy Privia Health Group stock.

What is PRVA's earnings growth forecast for 2025-2027?

(NASDAQ: PRVA) Privia Health Group's forecast annual earnings growth rate of 45.01% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 36.43%, and it is also forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Privia Health Group's earnings in 2025 is $18,167,000.On average, 21 Wall Street analysts forecast PRVA's earnings for 2025 to be $20,836,459, with the lowest PRVA earnings forecast at $12,054,150, and the highest PRVA earnings forecast at $29,704,869. On average, 21 Wall Street analysts forecast PRVA's earnings for 2026 to be $40,172,299, with the lowest PRVA earnings forecast at $28,929,960, and the highest PRVA earnings forecast at $54,243,674.

In 2027, PRVA is forecast to generate $55,018,584 in earnings, with the lowest earnings forecast at $45,805,769 and the highest earnings forecast at $73,616,415.

What is PRVA's revenue growth forecast for 2025-2027?

(NASDAQ: PRVA) Privia Health Group's forecast annual revenue growth rate of 20.45% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.

Privia Health Group's revenue in 2025 is $2,042,569,000.On average, 21 Wall Street analysts forecast PRVA's revenue for 2025 to be $420,542,227,651, with the lowest PRVA revenue forecast at $399,139,961,605, and the highest PRVA revenue forecast at $440,960,481,465. On average, 21 Wall Street analysts forecast PRVA's revenue for 2026 to be $424,847,281,166, with the lowest PRVA revenue forecast at $261,993,256,770, and the highest PRVA revenue forecast at $495,696,161,870.

In 2027, PRVA is forecast to generate $442,805,504,400 in revenue, with the lowest revenue forecast at $333,088,140,532 and the highest revenue forecast at $509,718,336,176.

What is PRVA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PRVA) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 17.25%.

What is PRVA's Price Target?

According to 9 Wall Street analysts that have issued a 1 year PRVA price target, the average PRVA price target is $30.44, with the highest PRVA stock price forecast at $34.00 and the lowest PRVA stock price forecast at $23.00.

On average, Wall Street analysts predict that Privia Health Group's share price could reach $30.44 by Nov 13, 2026. The average Privia Health Group stock price prediction forecasts a potential upside of 24.92% from the current PRVA share price of $24.37.

What is PRVA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PRVA) Privia Health Group's current Earnings Per Share (EPS) is $0.15. On average, analysts forecast that PRVA's EPS will be $0.17 for 2025, with the lowest EPS forecast at $0.10, and the highest EPS forecast at $0.24. On average, analysts forecast that PRVA's EPS will be $0.33 for 2026, with the lowest EPS forecast at $0.24, and the highest EPS forecast at $0.44. In 2027, PRVA's EPS is forecast to hit $0.45 (min: $0.37, max: $0.60).

What is PRVA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PRVA) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.